Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H MacCabe

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2022
COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapineRisha Govind, Daniela Fonseca de Freitas, Megan Pritchard, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2012
Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case reportBenjamin W J Spencer, Hugh R J Williams, Siobhan H Gee, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2019
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapineJad Kesserwani, Giouliana Kadra, Johnny Downs, et al.
Psychological Medicine|November 13, 2019
Psychotic experiences, psychiatric comorbidity and mental health need in the general population: a cross-sectional and cohort study in Southeast LondonVishal Bhavsar, Sarah Dorrington, Craig Morgan, et al.
Therapeutic Advances in Psychopharmacology|January 5, 2023
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidenceEbenezer Oloyede, Bethany Mantell, Julie Williams, et al.
Brain, Behavior, and Immunity|July 26, 2023
Early neutrophil trajectory following clozapine may predict clozapine response - Results from an observational study using electronic health recordsRowena Jones, Isabel Morales-Munoz, Adrian Shields, et al.
Journal of Clinical Psychopharmacology|April 25, 2017
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic ReviewJohn Lally, Steffi Malik, Eromona Whiskey, et al.
Journal of Clinical Psychopharmacology|August 18, 2017
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic ReviewJohn Lally, Steffi Malik, Amir Krivoy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2010
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort studyJames H MacCabe, Mats P Lambe, Sven Cnattingius, et al.
Psychiatry Research|January 28, 2014
Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP studyKim Donoghue, Gillian A Doody, Robin M Murray, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2022
COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapineRisha Govind, Daniela Fonseca de Freitas, Megan Pritchard, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2012
Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case reportBenjamin W J Spencer, Hugh R J Williams, Siobhan H Gee, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2019
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapineJad Kesserwani, Giouliana Kadra, Johnny Downs, et al.
Psychological Medicine|November 13, 2019
Psychotic experiences, psychiatric comorbidity and mental health need in the general population: a cross-sectional and cohort study in Southeast LondonVishal Bhavsar, Sarah Dorrington, Craig Morgan, et al.
Therapeutic Advances in Psychopharmacology|January 5, 2023
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidenceEbenezer Oloyede, Bethany Mantell, Julie Williams, et al.
Brain, Behavior, and Immunity|July 26, 2023
Early neutrophil trajectory following clozapine may predict clozapine response - Results from an observational study using electronic health recordsRowena Jones, Isabel Morales-Munoz, Adrian Shields, et al.
Journal of Clinical Psychopharmacology|April 25, 2017
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic ReviewJohn Lally, Steffi Malik, Eromona Whiskey, et al.
Journal of Clinical Psychopharmacology|August 18, 2017
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic ReviewJohn Lally, Steffi Malik, Amir Krivoy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2010
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort studyJames H MacCabe, Mats P Lambe, Sven Cnattingius, et al.
Psychiatry Research|January 28, 2014
Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP studyKim Donoghue, Gillian A Doody, Robin M Murray, et al.
Pageof 16